These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25267527)

  • 1. Dopaminergic Medication in Parkinson's Disease and Problem Gambling.
    Olley J; Blaszczynski A; Lewis S
    J Gambl Stud; 2015 Sep; 31(3):1085-106. PubMed ID: 25267527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of problem and pathological gambling in Parkinson's disease.
    Crockford D; Quickfall J; Currie S; Furtado S; Suchowersky O; El-Guebaly N
    J Gambl Stud; 2008 Dec; 24(4):411-22. PubMed ID: 18561000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
    Wolfschlag M; Håkansson A
    PLoS One; 2021; 16(6):e0252516. PubMed ID: 34061895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.
    Ray NJ; Miyasaki JM; Zurowski M; Ko JH; Cho SS; Pellecchia G; Antonelli F; Houle S; Lang AE; Strafella AP
    Neurobiol Dis; 2012 Dec; 48(3):519-25. PubMed ID: 22766031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
    Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
    Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic gambling in patients with Parkinson's disease.
    Gschwandtner U; Aston J; Renaud S; Fuhr P
    Clin Neuropharmacol; 2001; 24(3):170-2. PubMed ID: 11391129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic function and intertemporal choice.
    Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V
    Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
    van Eimeren T; Ballanger B; Pellecchia G; Miyasaki JM; Lang AE; Strafella AP
    Neuropsychopharmacology; 2009 Dec; 34(13):2758-66. PubMed ID: 19741594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy?
    Pignatti R; Brioschi A; Mauro A; Zamarian L; Wenter J; Semenza C
    Neurocase; 2012; 18(6):503-13. PubMed ID: 22224448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?
    Zand R
    Eur Neurol; 2008; 59(3-4):183-6. PubMed ID: 18230877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological gambling in Parkinson's disease--a review of the literature.
    Djamshidian A; Cardoso F; Grosset D; Bowden-Jones H; Lees AJ
    Mov Disord; 2011 Sep; 26(11):1976-84. PubMed ID: 21661054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management.
    Wolfschlag M; Håkansson A
    Pharmaceut Med; 2023 Jan; 37(1):37-52. PubMed ID: 36611111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological gambling induced by dopamine agonists].
    Gahr M; Connemann BJ; Schönfeldt-Lecuona CJ
    Fortschr Neurol Psychiatr; 2011 Aug; 79(8):470-4. PubMed ID: 21809260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
    Claassen DO; van den Wildenberg WPM; Ridderinkhof KR; Jessup CK; Harrison MB; Wooten GF; Wylie SA
    Behav Neurosci; 2011 Aug; 125(4):492-500. PubMed ID: 21604834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological gambling in Parkinson's disease: what are the risk factors and what is the role of impulsivity?
    Heiden P; Heinz A; Romanczuk-Seiferth N
    Eur J Neurosci; 2017 Jan; 45(1):67-72. PubMed ID: 27623191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.
    Abler B; Hahlbrock R; Unrath A; Grön G; Kassubek J
    Brain; 2009 Sep; 132(Pt 9):2396-402. PubMed ID: 19567700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced gambling disorder: A not so rare but underreported condition.
    Lanteri PF; Leguia A; Doladé NG; García GC; Figueras A
    Psychiatry Res; 2018 Nov; 269():593-595. PubMed ID: 30205352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson's disease.
    van der Vegt JPM; Hulme OJ; Madsen KH; Buhmann C; Bloem BR; Münchau A; Helmich RC; Siebner HR
    Neuroimage Clin; 2020; 28():102362. PubMed ID: 32798910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.